Real-time enrollment status for this macular telangiectasia type 2 clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 10:58 AM UTC
| NCT Number | NCT06971939 |
| Recruiting Status | Recruiting |
| Condition | Macular Telangiectasia Type 2 |
| Phase | Clinical Trial |
| Target Enrollment | 285 participants |
| Active Locations | 23 sites in the US |
| Sponsor | Neurotech Pharmaceuticals |
| Last Updated on CT.gov | June 1, 2026 (Jun 1, 2026) |
As of July 13, 2026: Clinical trial NCT06971939 is currently recruiting participants. This clinical trial study for macular telangiectasia type 2 is actively seeking new participants at 23 locations across the United States. The study is sponsored by Neurotech Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06971939 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06971939 was last updated Jun 1, 2026 (June 1, 2026). HelloStudys verifies this status automatically.